Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oxford Cannabinoid Technologies Holdings Plc (OP: OCTHF )

0.0051 UNCHANGED
Last Price Updated: 10:49 AM EDT, Apr 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0051
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0051
Today's Range 0.0051 - 0.0051
52wk Range 0.0045 - 0.0058
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn
--News Direct-- 
Via News Direct
Exposures Ethanol
Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn
Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF) CEO Clarissa Sowemimo Coker and CMO Dr Tim Corn speak to Thomas Warner from Proactive after the pharmaceutical group announced the... 
Via TheNewswire.com
Exposures Ethanol

Performance

YTD
-12.07%
-12.07%
1 Month
N/A
N/A
3 Month
-12.07%
-12.07%
6 Month
-12.07%
-12.07%
1 Year
+13.33%
+13.33%

More News

Read More
Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial
Via News Direct
Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial
Via TheNewswire.com
Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial
Via News Direct
Exposures Ethanol
Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial
Via TheNewswire.com
Exposures Ethanol
Oxford Cannabinoid Technologies in a "comfortable position" ahead of Phase 1 results release
Via News Direct
Oxford Cannabinoid Technologies in a "comfortable position" ahead of Phase 1 results release
Via TheNewswire.com
Oxford Cannabinoid Technologies "officially on the way" after first dosing
Via News Direct
Oxford Cannabinoid Technologies "officially on the way" after first dosing
Via TheNewswire.com
Oxford Cannabinoid Technologies announces "potential breakthrough" in field of oncology
Via News Direct
Topics Derivatives
Exposures Derivatives Ethanol
Oxford Cannabinoid Technologies announces "potential breakthrough" in field of oncology
Via TheNewswire.com
Topics Derivatives
Exposures Derivatives Ethanol
Oxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEO
Via News Direct
Oxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEO
Via TheNewswire.com
Proactive's John Savin publishes fresh research note on Oxford Cannabinoid Technologies
Via News Direct
Proactive's John Savin publishes fresh research note on Oxford Cannabinoid Technologies
Via TheNewswire.com
Oxford Cannabinoid Technologies with "lots to look forward to" after interims
Via TheNewswire.com
Oxford Cannabinoid Technologies with "lots to look forward to" after interims
Via News Direct
Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting
Via TheNewswire.com
Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting
Via News Direct
Data from pre-clinical study of OCT461201 shows positive results
Via News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.